cognosthx.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://cognosthx.com/sitemap_index.xml # --------------------------- # END YOAST
Meta Tags
Title Home – Cognos
Description ABOUT MISSION BOARD of DIRECTORS MANAGEMENT TEAM IP MANAGEMENT NEURO-ONCOLOGY BOARD REGULATORY AND COMPLIANCE CLINICAL RELEVANCE FOURTH MODALITY PUBLICATI
Keywords N/A
Server Information
WebSite cognosthx faviconcognosthx.com
Host IP 107.180.4.33
Location United States
Related Websites
Site Rank
More to Explore
cognosthx.com Valuation
US$2,810,846
Last updated: 2023-05-08 21:37:19

cognosthx.com has Semrush global rank of 3,765,523. cognosthx.com has an estimated worth of US$ 2,810,846, based on its estimated Ads revenue. cognosthx.com receives approximately 324,329 unique visitors each day. Its web server is located in United States, with IP address 107.180.4.33. According to SiteAdvisor, cognosthx.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$2,810,846
Daily Ads Revenue US$2,595
Monthly Ads Revenue US$77,839
Yearly Ads Revenue US$934,066
Daily Unique Visitors 21,622
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
cognosthx.com. A 7199 IP: 107.180.4.33
cognosthx.com. NS 3600 NS Record: ns28.domaincontrol.com.
cognosthx.com. NS 3600 NS Record: ns27.domaincontrol.com.
cognosthx.com. MX 3600 MX Record: 0 cognosthx-com.mail.protection.outlook.com.
cognosthx.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
HtmlToTextCheckTime:2023-05-08 21:37:19
ABOUT MISSION BOARD of DIRECTORS MANAGEMENT TEAM IP MANAGEMENT NEURO-ONCOLOGY BOARD REGULATORY AND COMPLIANCE CLINICAL RELEVANCE FOURTH MODALITY PUBLICATIONS NEWS SHAREHOLDER PORTAL SHAREHOLDER INFORMATION CONTACT Select Page Sinnais-g1-CGLC World’s first implantable device for the metronomic delivery of therapeutics for neuropathic disease mitigation. Targeted Delivery Unprecedented targeted delivery of advanced chemotherapeutics for persistent glioma treatment. SMART Diagnostic Monitoring 24/7 intelligent diagnostic sampling of treatment efficacy allowing rapid adjustment of therapeutics through secure remote WiFi access from anywhere in the world. Cognos Therapeutics Cognos Therapeutics Inc. (Cognos) is an advanced medical device company focused on creating unique technologies to radically advance the diagnosis and treatment of neuropathic diseases including tumor-based brain and spinal cancers, degenerative cognition disorders (such as Alzheimer’s and Parkinson’s disease),
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Sat, 30 Oct 2021 18:05:55 GMT
Server: Apache
Location: https://cognosthx.com/
Content-Type: text/html; charset=iso-8859-1

HTTP/2 200 
x-powered-by: PHP/7.3.30
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
set-cookie: swpm_session=75bd9c613ad9527835fefbc41d2ea916; path=/
content-type: text/html; charset=UTF-8
date: Sat, 30 Oct 2021 18:05:55 GMT
server: Apache
cognosthx.com Whois Information
Domain Name: COGNOSTHX.COM
Registry Domain ID: 1953491929_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-08-17T16:59:25Z
Creation Date: 2015-08-16T20:26:54Z
Registry Expiry Date: 2022-08-16T20:26:54Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS27.DOMAINCONTROL.COM
Name Server: NS28.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-18T04:22:20Z <<<